| Analysis | Metabolite Name | Measured Value | Units | Treatment | Tissue Type |
|---|---|---|---|---|---|
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 19.7 | nM | HFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 20.2 | nM | LFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 21.2 | nM | LFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 21.6 | nM | HFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 22.1 | nM | HFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 22.3 | nM | HFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 24.5 | nM | LFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 24.6 | nM | HFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 27.8 | nM | SW | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 28.3 | nM | LFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 28.4 | nM | SW | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 28.8 | nM | SW | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 29.6 | nM | HFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 29.6 | nM | LFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 30 | nM | LFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 30.7 | nM | SW | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 31.1 | nM | SW | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 32.3 | nM | LFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 32.7 | nM | SW | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 32.8 | nM | LFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 33.8 | nM | LFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 33.8 | nM | SW | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 34.4 | nM | HFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 34.5 | nM | LFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 36.8 | nM | HFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 38.6 | nM | SW | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 39.4 | nM | LFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 39.6 | nM | SW | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 40.5 | nM | SW | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 41.4 | nM | SW | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 41.5 | nM | HFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 41.5 | nM | LFD | Liver |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 45.3 | nM | SW | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 57.8 | nM | HFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 58.5 | nM | HFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 59 | nM | LFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 73.6 | nM | LFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 75.5 | nM | HFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 80.5 | nM | HFD | Plasma |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 84 | nM | HFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 89.5 | nM | LFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 95.4 | nM | SW | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 103.1 | nM | SW | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 108 | nM | SW | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 118 | nM | HFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 135 | nM | LFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 145 | nM | LFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 151.5 | nM | HFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 155 | nM | SW | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 171 | nM | LFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 177.5 | nM | HFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 185 | nM | LFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 191 | nM | SW | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 193 | nM | HFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 193 | nM | SW | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 216 | nM | LFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 242 | nM | SW | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 246 | nM | HFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 270 | nM | HFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 275 | nM | LFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 276 | nM | SW | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 291 | nM | HFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 301 | nM | SW | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 316 | nM | SW | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 325 | nM | HFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 348 | nM | SW | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 363 | nM | LFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 379.5 | nM | LFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 404.5 | nM | HFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 424 | nM | LFD | Muscle |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 523 | nM | HFD | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 555 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 582 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 584 | nM | SW | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 587 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 610 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 665 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 672 | nM | SW | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 673 | nM | SW | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 678 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 701 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 714 | nM | SW | Adipose |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 778 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 785 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 811 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 935 | nM | SW | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 973 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 993 | nM | SW | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 1020 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | 1200 | nM | SW | Hypothalmus |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | HFD | Adipose | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | HFD | Hypothalmus | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | HFD | Liver | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | HFD | Muscle | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | HFD | Plasma | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | LFD | Adipose | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | LFD | Hypothalmus | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | LFD | Liver | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | LFD | Muscle | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | LFD | Plasma | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | SW | Adipose | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | SW | Hypothalmus | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | SW | Liver | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | SW | Muscle | |
| ESI positive ion mode (Endocannabinoid analysis) | OEA | nM | SW | Plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|